Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 298.50
Ask: 301.50
Change: 13.00 (4.53%)
Spread: 3.00 (1.005%)
Open: 280.50
High: 304.50
Low: 280.50
Prev. Close: 287.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold

Thu, 24th Jun 2021 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Thursday and Wednesday:

----------

FTSE 100

----------

DEUTSCHE BANK RAISES GLAXOSMITHKLINE TO 'HOLD' (SELL) - PRICE TARGET 1,350 (1,300) PENCE

----------

CREDIT SUISSE RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,400 (1,300) PENCE - 'UNDERPERFORM'

----------

UBS RAISES SAINSBURY PRICE TARGET TO 290 (275) PENCE - 'BUY'

----------

BOFA RAISES DIAGEO PRICE TARGET TO 4,150 (3,900) PENCE - 'BUY'

----------

BERENBERG RAISES CRODA INTERNATIONAL PRICE TARGET TO 7,800 (7,400) PENCE - 'BUY'

----------

BERENBERG INITIATES PHOENIX GROUP WITH 'HOLD' - TARGET 790 PENCE

----------

CREDIT SUISSE RAISES NATWEST PRICE TARGET TO 260 (247) PENCE - 'OUTPERFORM'

----------

UBS RAISES BERKELEY GROUP PRICE TARGET TO 5,400 (5,240) PENCE - 'BUY'

----------

JEFFERIES CUTS CRH PRICE TARGET TO 4,449 (4,549) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES DS SMITH PRICE TARGET TO 470 (450) PENCE - 'NEUTRAL'

----------

HSBC CUTS BP TO 'HOLD' (BUY) - PRICE TARGET 360 (365) PENCE

----------

CREDIT SUISSE CUTS SEVERN TRENT PRICE TARGET TO 2,310 (2,340) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

HSBC RAISES IMI TO 'BUY' ('HOLD') - TARGET 2,065 (1,370) PENCE

----------

JPMORGAN CUTS WOOD GROUP PRICE TARGET TO 340 (350) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES TRAVIS PERKINS PRICE TARGET TO 2050 (1910) PENCE - 'BUY'

----------

BERNSTEIN RAISES ROYAL MAIL PRICE TARGET TO 650 (575) PENCE - 'MARKET-PERFORM'

----------

BERENBERG INITIATES BEAZLEY WITH 'HOLD' - TARGET 410 PENCE

----------

BERENBERG RAISES CINEWORLD GROUP PRICE TARGET TO 85 (70) PENCE - 'HOLD'

----------

BARCLAYS RAISES WORKSPACE GROUP PRICE TARGET TO 745 (700) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,180 (950) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES NEXT FIFTEEN COMMUNICATIONS TARGET TO 1,140 (940) PENCE - 'BUY'

----------

JEFFERIES RAISES KERRY GROUP PRICE TARGET TO 130 (127) EUR - 'BUY'

----------

RBC RAISES SMART METERING PRICE TARGET TO 1,060 (950) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES VICTORIA PRICE TARGET TO 1,110 (1,050) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
6 Apr 2021 08:19

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Read more
6 Apr 2021 08:08

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.

Read more
6 Apr 2021 07:53

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

Read more
21 Mar 2021 20:57

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe

By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, an EU official said on Sunday.Former EU member Britain ha...

Read more
19 Mar 2021 10:29

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Read more
19 Mar 2021 07:50

Oxford Biomedica says Sanofi pulling out of haemophilia project

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.

Read more
3 Feb 2021 13:56

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

Read more
29 Jan 2021 09:11

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots

* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses produced there (Adds detail, background)By Francesco Guarascio and Sabine SieboldBRUSSELS, Jan 29 (Re...

Read more
18 Jan 2021 17:18

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

Read more
8 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more
4 Nov 2020 09:40

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.